168 related articles for article (PubMed ID: 17024439)
1. Clear graft survival and immune reactions following emergency keratoplasty.
Maier P; Böhringer D; Reinhard T
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):351-9. PubMed ID: 17024439
[TBL] [Abstract][Full Text] [Related]
2. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
[TBL] [Abstract][Full Text] [Related]
3. Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.
Reinhard T; Reis A; Böhringer D; Malinowski M; Voiculescu A; Heering P; Godehardt E; Sunmacher R
Graefes Arch Clin Exp Ophthalmol; 2001 Jun; 239(5):367-72. PubMed ID: 11482341
[TBL] [Abstract][Full Text] [Related]
4. [Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor].
Reinhard T; Sundmacher R; Godehardt E; Heering P
Ophthalmologe; 1997 Jul; 94(7):496-500. PubMed ID: 9333395
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
Birnbaum F; Böhringer D; Sokolovska Y; Sundmacher R; Reinhard T
Transplantation; 2005 Apr; 79(8):964-8. PubMed ID: 15849551
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency.
Reinhard T; Spelsberg H; Henke L; Kontopoulos T; Enczmann J; Wernet P; Berschick P; Sundmacher R; Böhringer D
Ophthalmology; 2004 Apr; 111(4):775-82. PubMed ID: 15051212
[TBL] [Abstract][Full Text] [Related]
8. Prolonged organ culture reduces the incidence of endothelial immune reactions.
Maier P; Heinzelmann S; Böhringer D; Reinhard T
Eye (Lond); 2016 Jan; 30(1):127-32. PubMed ID: 26493031
[TBL] [Abstract][Full Text] [Related]
9. Third or greater penetrating keratoplasties: indications, survival, and visual outcomes.
Yildiz EH; Hoskins E; Fram N; Rapuano CJ; Hammersmith KM; Laibson PR; Cohen EJ
Cornea; 2010 Mar; 29(3):254-9. PubMed ID: 20118784
[TBL] [Abstract][Full Text] [Related]
10. Validation of tissue quality parameters for donor corneas, designated for emergency cases: corneal graft survival.
Rijneveld WJ; Wolff R; Völker-Dieben HJ; Pels E
Acta Ophthalmol; 2011 Dec; 89(8):734-40. PubMed ID: 20039852
[TBL] [Abstract][Full Text] [Related]
11. Indications and outcomes of keratoplasties in children during a 40-year period.
Majander A; Kivelä TT; Krootila K
Acta Ophthalmol; 2016 Sep; 94(6):618-24. PubMed ID: 27061670
[TBL] [Abstract][Full Text] [Related]
12. The influence of glaucoma history on graft survival after penetrating keratoplasty.
Reinhard T; Kallmann C; Cepin A; Godehardt E; Sundmacher R
Graefes Arch Clin Exp Ophthalmol; 1997 Sep; 235(9):553-7. PubMed ID: 9342604
[TBL] [Abstract][Full Text] [Related]
13. A comparison of lamellar and penetrating keratoplasty outcomes: a registry study.
Coster DJ; Lowe MT; Keane MC; Williams KA;
Ophthalmology; 2014 May; 121(5):979-87. PubMed ID: 24491643
[TBL] [Abstract][Full Text] [Related]
14. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A.
Reinhard T; Möller M; Sundmacher R
Cornea; 1999 Nov; 18(6):645-51. PubMed ID: 10571292
[TBL] [Abstract][Full Text] [Related]
15. [Acute and chronic immune reactions after penetrating keratoplasty with normal immune risk].
Reinhard T; Hutmacher M; Sundmacher R
Klin Monbl Augenheilkd; 1997 Mar; 210(3):139-43. PubMed ID: 9206744
[TBL] [Abstract][Full Text] [Related]
16. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
Birnbaum F; Schwartzkopff J; Scholz C; Reis A; Reinhard T
Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
Chow SP; Cook SD; Tole DM
Cornea; 2015 Nov; 34(11):1395-9. PubMed ID: 26382894
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study.
Birnbaum F; Mayweg S; Reis A; Böhringer D; Seitz B; Engelmann K; Messmer EM; Reinhard T
Eye (Lond); 2009 Nov; 23(11):2063-70. PubMed ID: 19151659
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis in repeat keratoplasty: per indication analysis in a large monocentric cohort].
Böhringer D; Reinhard T
Klin Monbl Augenheilkd; 2008 Jan; 225(1):50-6. PubMed ID: 18236370
[TBL] [Abstract][Full Text] [Related]
20. Long-term graft survival after penetrating keratoplasty.
Thompson RW; Price MO; Bowers PJ; Price FW
Ophthalmology; 2003 Jul; 110(7):1396-402. PubMed ID: 12867398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
